Unlock instant, AI-driven research and patent intelligence for your innovation.

Iloperidone inclusion compound included by beta-cyclodextrin and medicinal composition thereof

A technology of iloperidone and cyclodextrin, which is applied in the field of iloperidone β-cyclodextrin inclusion complex and its pharmaceutical composition, and can solve the problems such as failure to solve the rapid onset of iloperidone

Inactive Publication Date: 2012-07-11
CHONGQING PHARMA RES INST
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These published materials all use sustained-release injection technology, although it is beneficial to solve the problem of frequent drug use by patients, it also fails to solve the problem of rapid onset of iloperidone

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Iloperidone inclusion compound included by beta-cyclodextrin and medicinal composition thereof
  • Iloperidone inclusion compound included by beta-cyclodextrin and medicinal composition thereof
  • Iloperidone inclusion compound included by beta-cyclodextrin and medicinal composition thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] prescription:

[0054] Imperidone 10g

[0055] Hydroxypropyl β-cyclodextrin 500g

[0056] Tartaric acid 50g

[0057] 1mol / L sodium hydroxide solution appropriate amount

[0058] Water for injection up to 10L

[0059] The preparation is as follows: (50:1, 5:1)

[0060] Add an appropriate amount of water for injection into a stainless steel dispenser, under constant stirring, add 50 grams of tartaric acid buffer and 500 grams of hydroxypropyl β-cyclodextrin into the quantitative container and dissolve in water, add 10 grams of ipoperidone to the quantitative The container, continue to stir until the iloperidone is dissolved, add an appropriate amount of 1mol / L sodium hydroxide into the container, adjust the pH to about 4, and obtain a solution. Under stirring conditions, add water for injection to the above solution and adjust the final batch to 10L to obtain an injection solution.

[0061] The above injection solution is sterilized and filtered through a 0.22μm filter membrane, fil...

Embodiment 2

[0063] prescription:

[0064] Imperidone 20g

[0065] Hydroxypropyl β-cyclodextrin 1600g

[0066] Tartaric acid 20g

[0067] 1mol / L sodium hydroxide solution appropriate amount

[0068] Water for injection up to 10L

[0069] The preparation is as follows: (80:1, 1:1)

[0070] Add an appropriate amount of water for injection into a stainless steel dispenser. Under constant stirring, add 20 grams of tartaric acid buffer and 1600 grams of hydroxypropyl β-cyclodextrin to the quantitative container and dissolve in water. Add 20 grams of ipoperidone to the quantitative In the container, continue to stir until the iloperidone is dissolved, add an appropriate amount of 1mol / L sodium hydroxide to the container, and adjust the pH to about 4.5. Under stirring conditions, add water for injection to the above solution and adjust the final batch to 10L to obtain injection.

[0071] The above injection solution is sterilized and filtered through a 0.22 μm filter membrane, filtered into a sterilized con...

Embodiment 3

[0073] prescription:

[0074] Imperidone 40g

[0075] Hydroxypropyl β-cyclodextrin 400 g

[0076] Citric acid 300g

[0077] 1mol / L sodium hydroxide solution appropriate amount

[0078] Water for injection up to 10L

[0079] The preparation is as follows: (10:1, 7.5:1)

[0080] Add an appropriate amount of water for injection into a stainless steel dispenser, under constant stirring, add 300 grams of citric acid buffer and 400 grams of hydroxypropyl β-cyclodextrin into the quantitative container and dissolve in water, add 40 grams of ipoperidone In the quantitative container, continue to stir until the iloperidone is dissolved, add an appropriate amount of 1 mol / L sodium hydroxide to the container, adjust the pH to about 4.5, and obtain a solution. Under stirring conditions, add water for injection to the above solution and adjust the final batch to 10L to obtain injection.

[0081] The above injection solution is sterilized and filtered through a 0.22 μm filter membrane, filtered into a ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an iloperidone inclusion compound included by beta-cyclodextrin or a derivative thereof. The inclusion compound which can substantially improve the solubility of iloperidone in water can be conveniently prepared into various compositions or preparations, especially injections. The injections can reduce the stimulation of iloperidone to intramuscular injection parts. The inclusion compound or the composition preparations thereof can be used for treating schizophrenia.

Description

Technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to an inclusion complex of iloperidone with β-cyclodextrin or its derivatives. The inclusion complex can significantly improve the iloperidone in aqueous solvents. Solubility, it is convenient to make various compositions or preparations, especially injections, which can reduce the irritation of iloperidone to the intramuscular injection site, and the use of the inclusion compound or its composition preparations for the treatment of schizophrenia . Background technique [0002] Imperidone is an atypical antipsychotic drug used in the acute treatment of adult schizophrenia. It was approved for listing in the United States on May 6, 2009, under the trade name FANAPT, and the marketed dosage form is tablets, which are taken orally twice a day. [0003] The chemical structure of Imperidone is as follows: [0004] [0005] Since this product is used for the acute treatmen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/454A61K47/40A61P25/18
Inventor 王立钟晓东丁彦吉张涛邓杰
Owner CHONGQING PHARMA RES INST